Smithers has accumulated more than four decades of expertise in organising global events and curating enlightening and informative conferences that offer valuable networking prospects.
Attended by CEO's, senior principal scientists, researchers, presidents, chemistry directors, lecturers, R&D managers and pharmacologists to name a few.
The next conference will take place on 10-11 November 2026 at the Parkhotel Schönbrunn in Vienna, Austria. Register your interest here
The event spans over two days and includes a series of presentations on industry insights and collaborative discussions, making it an indispensable gathering for professionals working within the industry.
We explore topics such as.png)
Dr. Valeria Mazzoni, graduated in Industrial Biotechnology in 2015 at the University of Milan Bicocca, working for 2 years as a researcher at the same university. She obtained a master's degree in food quality in 2016 and has been working in Neotron since 2017, gaining experience in the R&D and packaging department (food and Pharma). From 2024 is the head of the E&L Unit of Neotron.
Alessio Mastrovito is a research scientist part of the Vantive E&L EU team. After his MSc in Industrial Chemistry at Bologna University, he worked as Analytical Chemist at a third-party lab conducting chemical testing on a wide range of medical devices, focusing on chemical characterization and ethylene oxide sterilization residuals analysis (according to ISO 10993 parts 7 and 18). He joined Vantive in 2021 as E&L SME, being key figure within a number of sustaining product and MDR remediation activities, acquiring experience on many products of the PD, HD and Acute portfolio.
Ron Brown is a toxicologist with 35 years of experience in regulatory toxicology and risk assessment. He recently retired from the US FDA after 25 years of service and currently directs a small company, Risk Science Consortium, LLC, that provides consultation and training in toxicological risk assessment and computational toxicology. At the FDA, Ron was the senior toxicologist responsible for developing and reviewing toxicological risk assessments of extractable and leachable (E&L) compounds from medical devices. Prior to his position at the US FDA, Ron served as a Senior Associate at the ILSI Risk Science Institute. He is founding member and former President of the Medical Device and Combination Products Specialty Section of the Society of Toxicology and former President of the Dose-Response Specialty Section of the Society for Risk Analysis.
I run the E&L Knowledge and Service Team at Bayer. We serve and support globally our project teams, working with marketed products and in the development. My 15 years of analytical experience in the academic research group of nutritionists, epidemiologists, public health experts and medical doctors is of great benefit in understanding the chemical behavior of drug products during a long-term contact with plastic and rubber components. Since starting at Bayer over 8 years ago, I have created practical solutions in our laboratory to confirm the safety of plastic and rubber materials together with our toxicologists. I represent Bayer in the ELSIE consortium and am known as a customer-focused E&L expert who can provide science-based solutions and answers at Bayer.
Trish joined Pfizer in February 2020 as a Global Risk Assessment Services Toxicologist in Drug Safety R&D. Trish has a background in Genetic Toxicology and over the last 12 years has built expertise in mutagenic impurity, extractable and leachable, and contamination risk assessments. In recent years, Trish participated in ICH M7 working group to develop Appendix 3 and co-authored hydrogen peroxide monograph. In addition, she authored the vinyl acetate monograph in the subsequent publication Bercu et al., (2018). Trish is also the co-chair of the Extractables and Leachables Safety Information Exchange (ELSIE) PDE and Sensitisation Sub-teams and is an active member of the EFPIA working group to support ICHQ3E.
Julia Martins has a strong academic and professional background in toxicological sciences, having earned a PhD in the field. Her expertise in analytical chemistry is supported by her master's degree, further strengthening her scientific foundation. Julia's extensive experience as a toxicologist in the pharmaceutical industry in Brazil has solidified her proficiency in toxicological assessments. Over the years, she has gained in-depth knowledge of regulatory guidelines and the evaluation of multiple toxicity endpoints within the context of toxicological risk assessments. Julia is currently a Scientist at Lhasa Limited where she contributes to the development of computational solutions for impurity assessment and read-across methodologies, including extractables and leachables (E&L) safety assessment.
.png?ext=.png){kind=logo}
GBA Pharma operates from two GMP-certified, FDA-inspected labs in southern Germany, specializing in pharmaceutical, biotherapeutic, and medical device analysis. With 170+ experts and decades of experience, GBA provides quality control, method development, raw material testing, stability studies, microbiological analysis, and regulatory support—ensuring compliance and quality throughout the product lifecycle for global clients.
In our qualified laboratory the relevant expert knowledge is available and we guarantee that your E&L study is thoroughly planned, the appropriate methods are competently chosen and the experimental phase is carried out by experienced and well-trained staff. Our Customers outsource each step to GBA and our senior regulatory affairs experts along with our highly experienced and qualified E&L experts team support at each step:
i) Planning and Risk Assessment
ii) Extractables Study
iii) Toxicological Assessment
iv) Leachables Study
Make use of GBA’s services and experience in case of the complete qualification of a packaging material, the identification of leachables, the response to a letter of deficiency, and many more.
Intertek Pharmaceutical & Medical Device Testing Laboratory Services
Intertek’s Switzerland laboratory in Reinach, near Basel, is a leading analytical testing facility serving pharmaceutical, medical device, drug delivery, chemical, packaging, polymer, and consumer healthcare sectors across Europe and globally.
The lab operates to GLP-compliant standards, is WHO-prequalified (since 2014), ISO 17025 and ISO 9001 certified, GMP compliant, and FDA inspected.
With over 30 years of experience, services include: extractables and leachables, method development and validation, pharmaceutical analytical support, impurities/genotoxic impurities analysis, particles and foreign matter investigation, counterfeit medicine investigations, ICH stability services, polymer analysis, medical device chemical characterisation, and quality control testing.
Get in Touch
Partner with us to accelerate your product development and ensure regulatory confidence.
Tel: +41 (61) 686 48 56
Email: business.support@intertek.com
Online: www.intertek.com/analytical-laboratories/switzerland
